How to Get Vanflyta (Quizartinib) Covered by Cigna in Washington: Complete Prior Authorization & Appeals Guide
Answer Box: Getting Vanflyta (Quizartinib) Covered by Cigna in Washington
Cigna requires prior authorization for Vanflyta (quizartinib) in FLT3-ITD-positive AML patients ≥18 years old with confirmed mutation via FDA-approved testing. Submit comprehensive documentation including baseline ECG showing QTc <450ms, REMS enrollment proof, and oncologist's medical necessity letter.